{"schema_version":"secwatch.filing_event.v1","accession":"0001171520-22-000305","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2022-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.084581+00:00","generated_at":"2026-06-25T20:35:06.133676+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ClearPoint Neuro Q1 revenue $5.0M, up 25% YoY; raises FY2022 guidance to $21-22M","bullets":["Record quarterly revenue of $5.0M, a 25% increase vs Q1 2021.","Biologics and drug delivery revenue $2.2M (+30% YoY); functional neurosurgery revenue $2.2M (+17%).","Operating expenses $7.1M, up from $4.8M in Q1 2021, driven by headcount and R&D.","Cash position $49.7M at March 31, 2022 vs $54.1M at year-end 2021.","Raised FY2022 revenue guidance to $21.0-22.0M, representing 30-35% growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001171520-22-000305","json":"https://secwatch.observer/filing/0001171520-22-000305.json","markdown":"https://secwatch.observer/filing/0001171520-22-000305.md","text":"https://secwatch.observer/filing/0001171520-22-000305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000305/0001171520-22-000305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000305/eps10228_clpt.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T20:35:06.133676+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}